Literature DB >> 31186351

LIM-domain transcription complexes interact with ring-finger ubiquitin ligases and thereby impact islet β-cell function.

Alexa K Wade1,2, Yanping Liu1,2, Maigen M Bethea1,2, Eliana Toren1,2, Hubert M Tse2,3, Chad S Hunter4,2.   

Abstract

Diabetes is characterized by a loss of β-cell mass, and a greater understanding of the transcriptional mechanisms governing β-cell function is required for future therapies. Previously, we reported that a complex of the Islet-1 (Isl1) transcription factor and the co-regulator single-stranded DNA-binding protein 3 (SSBP3) regulates the genes necessary for β-cell function, but few proteins are known to interact with this complex in β-cells. To identify additional components, here we performed SSBP3 reverse-cross-linked immunoprecipitation (ReCLIP)- and MS-based experiments with mouse β-cell extracts and compared the results with those from our previous Isl1 ReCLIP study. Our analysis identified the E3 ubiquitin ligases ring finger protein 20 (RNF20) and RNF40, factors that in nonpancreatic cells regulate transcription through imparting monoubiquitin marks on histone H2B (H2Bub1), a precursor to histone H3 lysine 4 trimethylation (H3K4me3). We hypothesized that RNF20 and RNF40 regulate similar genes as those regulated by Isl1 and SSBP3 and are important for β-cell function. We observed that Rnf20 and Rnf40 depletion reduces β-cell H2Bub1 marks and uncovered several target genes, including glucose transporter 2 (Glut2), MAF BZIP transcription factor A (MafA), and uncoupling protein 2 (Ucp2). Strikingly, we also observed that Isl1 and SSBP3 depletion reduces H2Bub1 and H3K4me3 marks, suggesting that they have epigenetic roles. We noted that the RNF complex is required for glucose-stimulated insulin secretion and normal mitochondrial reactive oxygen species levels. These findings indicate that RNF20 and RNF40 regulate β-cell gene expression and insulin secretion and establish a link between Isl1 complexes and global cellular epigenetics.
© 2019 Wade et al.

Entities:  

Keywords:  H2Bub1; H3K4me3; chromatin immunoprecipitation (ChiP); diabetes; histone modification; insulin secretion; islet; pancreas; transcription factor; transcription regulation

Mesh:

Substances:

Year:  2019        PMID: 31186351      PMCID: PMC6682733          DOI: 10.1074/jbc.RA118.006985

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  Bridge-1, a novel PDZ-domain coactivator of E2A-mediated regulation of insulin gene transcription.

Authors:  M K Thomas; K M Yao; M S Tenser; G G Wong; J F Habener
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding.

Authors:  Swarup K Chakrabarti; Joshua C James; Raghavendra G Mirmira
Journal:  J Biol Chem       Date:  2002-02-01       Impact factor: 5.157

3.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

4.  Ubiquitination of histone H2B by Rad6 is required for efficient Dot1-mediated methylation of histone H3 lysine 79.

Authors:  Huck Hui Ng; Rui-Ming Xu; Yi Zhang; Kevin Struhl
Journal:  J Biol Chem       Date:  2002-08-06       Impact factor: 5.157

5.  The Paf1 complex is essential for histone monoubiquitination by the Rad6-Bre1 complex, which signals for histone methylation by COMPASS and Dot1p.

Authors:  Adam Wood; Jessica Schneider; Jim Dover; Mark Johnston; Ali Shilatifard
Journal:  J Biol Chem       Date:  2003-07-21       Impact factor: 5.157

6.  Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47.

Authors:  Yi Qiu; Min Guo; Suming Huang; Roland Stein
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

7.  neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas.

Authors:  G Gradwohl; A Dierich; M LeMeur; F Guillemot
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

8.  Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast.

Authors:  Zu-Wen Sun; C David Allis
Journal:  Nature       Date:  2002-06-23       Impact factor: 49.962

9.  Gene silencing: trans-histone regulatory pathway in chromatin.

Authors:  Scott D Briggs; Tiaojiang Xiao; Zu-Wen Sun; Jennifer A Caldwell; Jeffrey Shabanowitz; Donald F Hunt; C David Allis; Brian D Strahl
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

10.  Expression of neurogenin3 reveals an islet cell precursor population in the pancreas.

Authors:  V M Schwitzgebel; D W Scheel; J R Conners; J Kalamaras; J E Lee; D J Anderson; L Sussel; J D Johnson; M S German
Journal:  Development       Date:  2000-08       Impact factor: 6.868

View more
  4 in total

1.  The Ldb1 transcriptional co-regulator is required for establishment and maintenance of the pancreatic endocrine lineage.

Authors:  Eliana Toren; Yanping Liu; Maigen Bethea; Alexa Wade; Chad S Hunter
Journal:  FASEB J       Date:  2022-08       Impact factor: 5.834

Review 2.  Role of the Transcription Factor MAFA in the Maintenance of Pancreatic β-Cells.

Authors:  Wataru Nishimura; Hiroaki Iwasa; Munkhtuya Tumurkhuu
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

3.  LDB1-mediated transcriptional complexes are sensitive to islet stress.

Authors:  Yanping Liu; Jessica D Kepple; Anath Shalev; Chad S Hunter
Journal:  Islets       Date:  2022-12-31       Impact factor: 2.308

Review 4.  Regulation of Glucose, Fatty Acid and Amino Acid Metabolism by Ubiquitination and SUMOylation for Cancer Progression.

Authors:  Shunqin Zhu; Hongyu Gu; Cheng Peng; Fanwei Xia; Huan Cao; Hongjuan Cui
Journal:  Front Cell Dev Biol       Date:  2022-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.